Current stage -Stage II - Page 3 of 3 Posts on Medivizor
Navigation Menu

Current stage -Stage II Posts on Medivizor

How should biochemical recurrence be defined after external beam radiation therapy?

Posted by on Jun 28, 2014 in Prostate cancer | 0 comments

In a nutshell The authors aimed to evaluate if a new definition of biochemical recurrence is appropriate in prostate cancer treated with radical external beam radiation. Some background Prostate-specific antigen is a protein that is found at higher levels in the blood when prostate cancer is present. After prostatectomy (surgery to remove the...

Read More

Surgery or targeted radiotherapy?

Posted by on Nov 24, 2013 in Prostate cancer | 0 comments

In a nutshell This examined survival rates of radical prostatectomy compared with intensity modulated radiotherapy (IMRT) among patients with localized (confined) prostate cancer.  Some background Radical prostatectomy or RP (surgical removal of the prostate gland and some healthy tissue around it) and radiotherapy are the most common...

Read More

Comparing survival for surgery versus radiation therapy in patients with prostate cancer

Posted by on Jun 26, 2013 in Prostate cancer | 0 comments

In a nutshell This study compared survival rates for patients with prostate cancer who were treated with either surgery to remove the prostate (radical prostatectomy) or radiation therapy (external beam radiotherapy).  Some background The prostate is a gland in the reproductive system of men, which is found under the urinary bladder. In a...

Read More

Proton beam radiation therapy with or without androgen suppression for intermediate risk prostate cancer

Posted by on Jun 2, 2013 in Prostate cancer | 0 comments

In a nutshell This phase 3 trial aims to determine if androgen suppression along with high dose proton radiation therapy offers more benefit than proton radiation therapy alone. The main outcome investigated is freedom from treatment failure. The details Freedom from treatment failure represents successful treatment with no local cancer...

Read More

Testosterone as a treatment in men who have had prostate cancer, is it a viable option to improve men’s health?

Posted by on May 3, 2013 in Prostate cancer | 0 comments

In a nutshell This article reviews the use of testosterone treatment in men who have had prostate cancer.  Although not currently used as a treatment method, there is a small amount of evidence which shows that it does not increase the risk of prostate cancer recurrence or progression. Some background Testosterone is produced largely by the...

Read More

The impact of 6 vs 18 months of androgen-suppression therapy, with or without Zolendronic Acid, on quality of life in men with prostate cancer

Posted by on Mar 3, 2013 in Prostate cancer | 0 comments

In a nutshell This clinical trial evaluated the quality of life of men with locally advanced prostate cancer (PCa) treated with Leuprorelin and radiotherapy, with or without Zolendronic Acid (ZA). Quality of life measures improved with shorter duration of Leuprorelin treatment, regardless of combining ZA. Some background Prostate cancer...

Read More

Recurrence rate after surgical prostate removal in men older than 70 years of age

Posted by on Feb 26, 2013 in Prostate cancer | 0 comments

Due to the increase in life expectancy, there exists an increasing number of patients with prostate cancer (PCA) in many populations. However, there is no consensus on screening and treatment of PCA in the medical fraternity. This paper investigated the oncological outcomes of radical prostatectomy (RP) in older men (> 70) compared to RP outcomes in...

Read More